drugset / Trial / NCT03274284

Chemoradiotherapy for Recurrent T1G3 Bladder Cancer

NCT03274284

Phase 4 Unknown 20 enrolled Assiut University
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the short term results of chemoradiation in case of T1G3 BC after BCG failure.

Timeline

Start
2017-10
Primary completion
2019-11
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified